CD44vRAに対する抗体およびその使用方法 - YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM

Title:

CD44vRAに対する抗体およびその使用方法

Document Type and Number:

Japanese Patent JP2008500004

Kind Code:

A

Abstract:

The present invention concerns antibodies specific for a CD44 variant protein derived from synovial cells of Rheumatoid Arthritis (RA) patients and novel cell hybridomas releasing monoclonal antibodies (mAbs) specific for said RA specific CD44 variant and mAb expressed thereby. The antibodies are useful in methods for identifying, isolating or targeting the specific CD44 variant.

More Like This:

WO/2013/111754	EXPRESSION VECTOR AND METHOD FOR PRODUCING PROTEIN
WO/2001/053467	RECOMBINANT FLAVIVIRUSES AND METHODS OF USE THEREOF
JP2004518404	Mutant strains capable of producing chemically diversified proteins by incorporating unconventional amino acids

Inventors:

Naol, david
Golan, Itoshak

Application Number:

JP2006520103A

Publication Date:

January 10, 2008

Filing Date:

July 15, 2004

Export Citation:

Click for automatic bibliography generation Help

Assignee:

YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM

International Classes:

C12N15/09; A61K39/395; A61P19/02; A61P29/00; A61P37/00; C07K1/22; C07K16/00; C07K16/18; C07K16/28; C07K16/46; C07K19/00; C12N5/10; C12N5/20; C12N15/02; C12N15/13; G01N33/53; C12P21/08

Foreign References:

WO2003072606A2	2003-09-04
WO2000075312A1	2000-12-14

Attorney, Agent or Firm:

Nobuaki Kazehaya
Noriko Asano

Previous Patent: 新規ＥＩＭＥＲＩＡ遺伝子および対応タンパク質の使用

Next Patent: 癌及び感染症の免疫療法のための組成物及び方法